azacitidine has been researched along with Leukemia, Myelomonocytic, Juvenile in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 10 (52.63) | 2.80 |
| Authors | Studies |
|---|---|
| Hirabayashi, S; Honda, Y; Kakuda, H; Manabe, A; Meguro, T; Moritake, H; Muramatsu, H; Nanjo, Y; Ozono, S; Sakashita, K; Sano, H; Wakamatsu, M; Yasui, M; Yoshida, N | 1 |
| Igarashi, K; Kawasaki, Y; Muramatsu, H; Takebayashi, A; Yamamoto, M | 1 |
| Balceiro, R; Ikeuty, P; Lee, MLM; Lopes, LF; Lorand-Metze, I; Metze, K; Oliveira, AF; Tansini, A; Toledo, T; Villela, N | 1 |
| Akiyama, H; Hagino, T; Hidai, H; Motomura, S; Murai, Y; Saga, R; Sato, T | 1 |
| Aschenbrenner, DS | 1 |
| Chien, KS; Class, C; Darbaniyan, F; Do, KA; Estecio, M; Ganan-Gomez, I; Garcia-Manero, G; Kanagal-Shamanna, R; Lockyer, P; Lu, Y; Montalban-Bravo, G; Sasaki, K; Soltysiak, KA; Wei, Y; Yang, H; Zheng, H | 1 |
| Abe, H; Hamada, S; Hyakuna, N; Nakanishi, K; Oshiro, T | 1 |
| Dworzak, MN; Hasle, H; Hoogendijk, R; Huitema, ADR; Janssen, JM; Laille, EJ; Lopez-Yurda, M; Niemeyer, CM; Rubio-San-Simón, A; van den Heuvel-Eibrink, MM; van Eijkelenburg, NKA; van Tinteren, H; Zecca, M; Zwaan, CM | 1 |
| Ali, KA; Anderson, E; Anderson, W; Dhar, A; Gu, CJ; Hübner, J; Kita, R; Lacher, MD; Loh, ML; Richardson, M; Santaguida, MT; Stieglitz, E; Strachan, DC; Tasian, SK; Yam, G | 1 |
| Baruchel, A; Baumann, I; Benettaib, B; Biserna, N; Flotho, C; Gaudy, A; Klingebiel, T; Lipka, DB; Locatelli, F; Menezes, D; Micalizzi, C; Michel, G; Niemeyer, CM; Nöllke, P; Nysom, K; Patturajan, M; Poon, J; Rives, S; Rössig, C; Schmugge Liner, M; Schönung, M; Simcock, M; Starý, J; van den Heuvel-Eibrink, MM; Zecca, M | 1 |
| Bertaina, A; Cefalo, MG; Di Florio, F; Girardi, K; Leoncini, PP; Locatelli, F; Niemeyer, C; Pitisci, A; Tocco, V; Vitullo, P | 1 |
| Flotho, C; Lübbert, M; Sommer, S | 1 |
| Algeri, M; Locatelli, F; Merli, P; Strocchio, L | 1 |
| Aumann, K; Daskalakis, M; Erlacher, M; Flotho, C; Gallego-Villar, L; Hartmann, M; Krombholz, CF; Lipka, DB; Niemeyer, CM; Panda, PK; Plass, C; Sahoo, SS; Wlodarski, MW | 1 |
| Flotho, C | 1 |
| Adamcakova, J; Bodova, I; Bubanska, E; Cermak, M; Doczyova, D; Fabri, O; Galisova, V; Horakova, J; Kolenova, A; Laluhova Striezencova, Z; Panikova, A; Skalicka, K; Svec, P; Sykora, T; Vaska, A | 1 |
| Fisher, KE; Gaikwad, AS; Hashmi, SK; Loh, ML; Lopez-Terrada, DH; Marcogliese, AN; Niemeyer, CM; Punia, JN; Rao, P; Rau, RE; Ringrose, J; Roy, A | 1 |
| Candás, A; Cseh, A; Dworzak, M; Flotho, C; Furlan, I; Groß-Wieltsch, U; Hasle, H; Kulozik, AE; Locatelli, F; Masetti, R; Niemeyer, CM; Olcay, L; Schmugge, M; Strahm, B; Suttorp, M; van den Heuvel-Eibrink, MM; Yoshimi, A | 1 |
| Batz, C; Flotho, C; Furlan, I; Lübbert, M; Mohr, B; Niemeyer, CM; Suttorp, M | 1 |
3 review(s) available for azacitidine and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Decitabine; DNA Methylation; Epigenesis, Genetic; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Myelodysplastic Syndromes | 2018 |
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.
Topics: Azacitidine; Child, Preschool; Female; GTP Phosphohydrolases; Humans; Infant; Infant, Newborn; Leukemia, Myelomonocytic, Juvenile; Male; Membrane Proteins; Mutation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins p21(ras) | 2018 |
Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Child; DNA Methylation; Epigenesis, Genetic; Humans; Leukemia, Myelomonocytic, Juvenile; Mutation | 2019 |
2 trial(s) available for azacitidine and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
Azacitidine (Vidaza
Topics: Adult; Azacitidine; Child; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile; Myelodysplastic Syndromes; Remission Induction | 2023 |
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Topics: Adult; Azacitidine; Child; DNA Methylation; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Mutation | 2021 |
14 other study(ies) available for azacitidine and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Child, Preschool; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Retrospective Studies; Treatment Outcome | 2022 |
Azacitidine as a bridge to transplantation in juvenile myelomonocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile | 2022 |
Topics: Antigens, CD34; Azacitidine; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Juvenile; Lymphocyte Count | 2022 |
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia.
Topics: Aged, 80 and over; Azacitidine; Humans; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Leukemoid Reaction; Leukocytosis; Male | 2022 |
Drug Receives New Indication for Juvenile Myelomonocytic Leukemia.
Topics: Azacitidine; Child; Child, Preschool; Humans; Leukemia, Myelomonocytic, Juvenile | 2022 |
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.
Topics: Animals; Azacitidine; Humans; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Mice; Myelodysplastic Syndromes; Transcriptome | 2022 |
[Successful second allogeneic hematopoietic stem cell transplantation with azacitidine as bridging therapy for relapsed juvenile myelomonocytic leukemia].
Topics: Azacitidine; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Male; Prospective Studies; Recurrence | 2023 |
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay.
Topics: Azacitidine; Child; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Tretinoin | 2023 |
Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.
Topics: Antigens, CD34; Azacitidine; Binding Sites; Child; Child, Preschool; CpG Islands; DNA Methylation; Epigenesis, Genetic; Female; Humans; Leukemia, Myelomonocytic, Juvenile; Male; Sequence Analysis, DNA | 2018 |
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Carcinogenesis; Humans; Leukemia, Myelomonocytic, Juvenile; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approaches.
Topics: Azacitidine; Child; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Male; Retrospective Studies; Slovakia | 2019 |
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 7; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Precursor Cells, B-Lymphoid; Remission Induction | 2019 |
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Child; Child, Preschool; Cytogenetic Analysis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Myelodysplastic Syndromes; Prognosis; Remission Induction; Retrospective Studies | 2015 |
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Cells; Calcitonin; Chromosomes, Human, Pair 7; Clone Cells; Combined Modality Therapy; CpG Islands; DNA Methylation; Genes, ras; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Monosomy; Neoplasm Proteins; Point Mutation; Promoter Regions, Genetic; Protein Precursors; Remission Induction | 2009 |